Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China

Fig. 3

Comparison of HER2 status between single block assessment and dual block assessment in total patients. HER2 3+ rate of dual block assessment was significantly higher than that of both block 1 and block2 (*P < 0.001). HER2 2+ rate of dual block assessment was higher than that of both block 1 and block 2 in total patients (*P < 0.001). HER2 negative rate was lower in dual block assessment than in single block assessment (*P < 0.001)

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us